The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Zilli T
- Dirix P
- Heikkilä R
- Liefhooghe N
- Siva S
- Gomez-Iturriaga A
- Everaerts W
- Otte F
- Shelan M
- Mercier C
- Achard V
- Thon K
- Stellamans K
- Moon D
- Papachristofilou A
- Scorsetti M
- Gückenberger M
- Ameye F
- Zapatero A
- Van De Voorde L
- López Campos F
- Couñago F
- Jaccard M
- Spiessens A
- Semac I
- Vanhoutte F
- Goetghebeur E
- Reynders D
- Ost P
Grupos
Abstract
Optimal local treatment for nodal oligorecurrent prostate cancer is unknown. The randomized phase 2 PEACE V-STORM trial will explore the best treatment approach in this setting. Early results on the acute toxicity profile are projected to be published in quarter 3, 2021.
Datos de la publicación
- ISSN/ISSNe:
- 2405-4569, 2405-4569
- Tipo:
- Editorial Material
- Páginas:
- 241-244
- PubMed:
- 33386290
- Factor de Impacto:
- 1,453 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
European Urology Focus ELSEVIER
Citas Recibidas en Web of Science: 23
Documentos
- No hay documentos
Filiaciones
Keywords
- RADIOTHERAPY; RECURRENCE
Cita
Zilli T,Dirix P,Heikkilä R,Liefhooghe N,Siva S,Gomez A,Everaerts W,Otte F,Shelan M,Mercier C,Achard V,Thon K,Stellamans K,Moon D,Conde A,Papachristofilou A,Scorsetti M,Gückenberger M,Ameye F,Zapatero A,Van De Voorde L,López F,Couñago F,Jaccard M,Spiessens A,Semac I,Vanhoutte F,Goetghebeur E,Reynders D,Ost P. The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases. Eur. Urol. Focus. 2021. 7(2):p. 241-244. IF:5,952. (1).
Portal de investigación